A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 08 08 2020
revised: 20 05 2021
accepted: 28 07 2021
pubmed: 7 8 2021
medline: 16 11 2021
entrez: 6 8 2021
Statut: ppublish

Résumé

Secondary malignant neoplasms (SMNs) and cardiovascular diseases induced by chemotherapy and radiotherapy represent the main cause of excess mortality for early-stage Hodgkin lymphoma patients, especially when the mediastinum is involved. Conformal radiotherapy techniques such as Intensity-Modulated Radiation Therapy (IMRT) could allow a reduction of the dose to the organs-at-risk (OARs) and therefore limit long-term toxicity. We performed a systematic review of the current literature regarding comparisons between IMRT and conventional photon beam radiotherapy, or between different IMRT techniques, for the treatment of mediastinal lymphoma. IMRT allows a substantial reduction of the volumes of OARs exposed to high doses, reducing the risk of long-term toxicity. This benefit is conterbalanced by the increase of volumes receiving low doses, that could potentially increase the risk of SMNs. Treatment planning should be personalized on patient and disease characteristics. Dedicated techniques such as "butterfly" VMAT often provide the best trade-off.

Sections du résumé

BACKGROUND BACKGROUND
Secondary malignant neoplasms (SMNs) and cardiovascular diseases induced by chemotherapy and radiotherapy represent the main cause of excess mortality for early-stage Hodgkin lymphoma patients, especially when the mediastinum is involved. Conformal radiotherapy techniques such as Intensity-Modulated Radiation Therapy (IMRT) could allow a reduction of the dose to the organs-at-risk (OARs) and therefore limit long-term toxicity.
METHODS METHODS
We performed a systematic review of the current literature regarding comparisons between IMRT and conventional photon beam radiotherapy, or between different IMRT techniques, for the treatment of mediastinal lymphoma.
RESULTS AND CONCLUSIONS CONCLUSIONS
IMRT allows a substantial reduction of the volumes of OARs exposed to high doses, reducing the risk of long-term toxicity. This benefit is conterbalanced by the increase of volumes receiving low doses, that could potentially increase the risk of SMNs. Treatment planning should be personalized on patient and disease characteristics. Dedicated techniques such as "butterfly" VMAT often provide the best trade-off.

Identifiants

pubmed: 34358649
pii: S1040-8428(21)00225-0
doi: 10.1016/j.critrevonc.2021.103437
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103437

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Michela Buglione (M)

Università degli Studi di Brescia, Department of Radiation Oncology, Brescia University, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: michela.buglione@unibs.it.

Andrea Emanuele Guerini (AE)

Università degli Studi di Brescia, Department of Radiation Oncology, Brescia University, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: a.e.guerini@gmail.com.

Andrea Riccardo Filippi (AR)

Radiation Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy. Electronic address: a.filippi@smatteo.pv.it.

Luigi Spiazzi (L)

Department of Radiation Oncology, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: luigi.spiazzi@asst-spedalicivili.it.

Nadia Pasinetti (N)

Università degli Studi di Brescia, Department of Radiation Oncology, Brescia University, P.le Spedali Civili 1, 25123 Brescia, Italy; Radiation Oncology Service, ASST Valcamonica Esine, Italy. Electronic address: nadia.pasinetti@aol.com.

Alessandro Magli (A)

Department of Radiation Oncology, Udine General Hospital, Udine, Italy. Electronic address: maglialessandro@hotmail.com.

Cristian Toraci (C)

Department of Radiation Oncology, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: c.toraci@gmail.com.

Paolo Borghetti (P)

Department of Radiation Oncology, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: paolobor82@yahoo.it.

Luca Triggiani (L)

Università degli Studi di Brescia, Department of Radiation Oncology, Brescia University, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: triggioluca@hotmail.it.

Alessandro Alghisi (A)

Department of Radiation Oncology, Alessandro Manzoni Hospital, Lecco, Italy. Electronic address: ale.alghisi@libero.it.

Gianluca Costantino (G)

Radiation Oncology Service, ASST Valcamonica Esine, Italy. Electronic address: costantino.gianlu@gmail.com.

Francesco Bertagna (F)

Nuclear Medicine Department, University of Brescia and Spedali Civili of Brescia, Brescia, Italy. Electronic address: francesco.bertagna@unibs.it.

Niccolò Giaj Levra (N)

Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Italy. Electronic address: gmnicco@yahoo.it.

Ludovica Pegurri (L)

Department of Radiation Oncology, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: ludovicapegurri@libero.it.

Stefano Maria Magrini (SM)

Università degli Studi di Brescia, Department of Radiation Oncology, Brescia University, P.le Spedali Civili 1, 25123 Brescia, Italy. Electronic address: stefano.magrini@unibs.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH